BioNTech SE (BNTX) Sales of Property, Plant and Equipment (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 698,426.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 698,426.11 |
| Dec 31, 2025 | 698,426.11 |
| Sep 30, 2025 | 3.39 Mn |
| Sep 30, 2025 | 3.39 Mn |
| Jun 30, 2025 | 565,979.84 |
| Jun 30, 2025 | 565,979.84 |
| Mar 31, 2025 | 525,942.22 |
| Mar 31, 2025 | 525,942.22 |
| Dec 31, 2024 | 748,016.78 |
| Dec 31, 2024 | 748,016.78 |
| Sep 30, 2024 | 329,465.85 |
| Sep 30, 2024 | 329,465.85 |
| Jun 30, 2024 | 215,377.52 |
| Jun 30, 2024 | 215,377.52 |
| Dec 31, 2023 | 107,593.99 |
| Dec 31, 2023 | 107,593.99 |
| Sep 30, 2023 | -870,872.38 |
| Sep 30, 2023 | -870,872.38 |
| Dec 31, 2022 | 204,049.47 |
| Dec 31, 2022 | 204,049.47 |
| Sep 30, 2022 | 403,309.73 |
| Sep 30, 2022 | 403,309.73 |
| Dec 31, 2021 | 2.29 Mn |
| Dec 31, 2021 | 2.29 Mn |
| Sep 30, 2021 | 1.65 Mn |
| Sep 30, 2021 | 1.65 Mn |
| Jun 30, 2021 | 361,281.43 |
| Jun 30, 2021 | 361,281.43 |
| Mar 31, 2021 | 1.09 |
| Mar 31, 2021 | 1.09 |
| Dec 31, 2020 | 1.43 |
| Dec 31, 2020 | 1.43 |
| Dec 31, 2019 | -628,712.20 |
| Dec 31, 2019 | -628,712.20 |
| Dec 31, 2018 | -644,084.30 |
| Dec 31, 2018 | -644,084.30 |